PTPI·71678J100·UW·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
PTPI (Petros Pharmaceuticals, Inc.) is held by 0 institutional investors as of Q2 2025. Net institutional sentiment: Bearish.
See how PTPI's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer